Aptose Average Payables from 2010 to 2026
| APS Stock | CAD 2.26 0.01 0.44% |
Average Payables | First Reported 2010-12-31 | Previous Quarter 343.4 K | Current Value 326.2 K | Quarterly Volatility 209.3 K |
Check Aptose Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aptose Biosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 27.4 K, Interest Expense of 159.5 K or Selling General Administrative of 6.8 M, as well as many indicators such as Price To Sales Ratio of 2.8 K, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Aptose financial statements analysis is a perfect complement when working with Aptose Biosciences Valuation or Volatility modules.
Aptose | Average Payables |
Evaluating Aptose Biosciences's Average Payables across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Aptose Biosciences's fundamental strength.
Latest Aptose Biosciences' Average Payables Growth Pattern
Below is the plot of the Average Payables of Aptose Biosciences over the last few years. It is the average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers. Aptose Biosciences' Average Payables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aptose Biosciences' overall financial position and show how it may be relating to other accounts over time.
| Average Payables | 10 Years Trend |
|
Average Payables |
| Timeline |
Aptose Average Payables Regression Statistics
| Arithmetic Mean | 390,242 | |
| Geometric Mean | 361,569 | |
| Coefficient Of Variation | 53.63 | |
| Mean Deviation | 120,842 | |
| Median | 298,610 | |
| Standard Deviation | 209,287 | |
| Sample Variance | 43.8B | |
| Range | 856.3K | |
| R-Value | (0.59) | |
| Mean Square Error | 30.5B | |
| R-Squared | 0.35 | |
| Significance | 0.01 | |
| Slope | (24,413) | |
| Total Sum of Squares | 700.8B |
Aptose Average Payables History
About Aptose Biosciences Financial Statements
Aptose Biosciences investors utilize fundamental indicators, such as Average Payables, to predict how Aptose Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Average Payables | 343.4 K | 326.2 K |
Other Information on Investing in Aptose Stock
Aptose Biosciences financial ratios help investors to determine whether Aptose Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aptose with respect to the benefits of owning Aptose Biosciences security.